Published in J Infect Dis on September 01, 1987
Acyclovir treatment for varicella does not lower gpI and IE-62 (p170) antibody responses to varicella-zoster virus in normal children. J Clin Microbiol (1990) 0.99
A phase 1/2 study of an adjuvanted varicella-zoster virus subunit vaccine in autologous hematopoietic cell transplant recipients. Blood (2014) 0.93
COMMENTARY: Significantly less anti-gC antibody detectable in sera collected after varicella vaccination than after the disease varicella. Pediatr Infect Dis J (2012) 0.75
A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med (2005) 17.06
The p21 src genes of Harvey and Kirsten sarcoma viruses originate from divergent members of a family of normal vertebrate genes. Nature (1981) 8.44
Analysis of two divergent rat genomic clones homologous to the transforming gene of Harvey murine sarcoma virus. Proc Natl Acad Sci U S A (1981) 5.51
Thymidine kinase from herpes simplex virus phosphorylates the new antiviral compound, 9-(2-hydroxyethoxymethyl)guanine. J Biol Chem (1978) 5.43
Dual evolutionary origin for the rat genetic sequences of Harvey murine sarcoma virus. J Virol (1980) 4.63
Inhibition of herpes simplex virus-induced DNA polymerase activity and viral DNA replication by 9-(2-hydroxyethoxymethyl)guanine and its triphosphate. J Virol (1979) 4.53
Serologic response to varicella-zoster membrane antigens measured by direct immunofluorescence. J Infect Dis (1974) 4.41
Nucleotide sequence of the p21 transforming protein of Harvey murine sarcoma virus. Science (1982) 3.55
Human genome contains four genes homologous to transforming genes of Harvey and Kirsten murine sarcoma viruses. Proc Natl Acad Sci U S A (1982) 3.48
Internal Hydrocephalus Following Cerebral Thrombosis, in an Infant. Proc R Soc Med (1937) 3.45
Structural similarities between the Ca2+-dependent regulatory proteins of 3':5'-cyclic nucleotide phosphodiesterase and actomyosin ATPase. J Biol Chem (1976) 3.38
Neutralization of divergent human immunodeficiency virus type 1 variants and primary isolates by IAM-41-2F5, an anti-gp41 human monoclonal antibody. Proc Natl Acad Sci U S A (1994) 3.33
The L1 major capsid protein of human papillomavirus type 11 recombinant virus-like particles interacts with heparin and cell-surface glycosaminoglycans on human keratinocytes. J Biol Chem (1999) 3.16
Measles outbreak in a fully immunized secondary-school population. N Engl J Med (1987) 2.75
Prevention of varicella by zoster immune globulin. N Engl J Med (1969) 2.57
Functional organization of the Harvey murine sarcoma virus genome. J Virol (1980) 2.46
Inhibition by acyclovir of cell growth and DNA synthesis of cells biochemically transformed with herpesvirus genetic information. Virology (1980) 2.18
Transformation by cloned Harvey murine sarcoma virus DNA: efficiency increased by long terminal repeat DNA. Science (1980) 2.05
Enzyme-linked immunosorbent assay for susceptibility to varicella. J Infect Dis (1983) 2.03
Metabolic activation of the nucleoside analog 9-[( 2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine in human diploid fibroblasts infected with human cytomegalovirus. Proc Natl Acad Sci U S A (1985) 2.02
A Syndrome Characterized by Ectodermal Dysplasia, Polydactyly, Chondro-Dysplasia and Congenital Morbus Cordis: Report of Three Cases. Arch Dis Child (1940) 2.00
Vitamin-C Deficiency and Periostitis of Both Ulnae.? Scurvy. Proc R Soc Med (1939) 1.97
Enzymatic phosphorylation of acyclic nucleoside analogs and correlations with antiherpetic activities. Biochem Pharmacol (1981) 1.92
The effect of insulin on growth, nitrogen excretion and respiratory metabolism. Biochem J (1931) 1.89
Varicella vaccine (VARIVAX) in healthy children and adolescents: results from clinical trials, 1987 to 1989. Pediatrics (1991) 1.86
Separation of infectious Varicella-Zoster virus from human embryonic lung fibroblasts. Virology (1967) 1.85
Heteroduplex analysis of cloned rat endogenous replication-defective (30 S) retrovirus and Harvey murine sarcoma virus. Virology (1980) 1.81
Altered thymidine-thymidylate kinases from strains of herpes simplex virus with modified drug sensitivities to acyclovir and (E)-5-(2-bromovinyl)-2'-deoxyuridine. Mol Pharmacol (1983) 1.75
Generation of BALB-MuSV and Ha-MuSC by type C virus transduction of homologous transforming genes from different species. Cell (1981) 1.73
Autophosphorylation of v-Ha-ras p21 is modulated by amino acid residue 12. Proc Natl Acad Sci U S A (1984) 1.68
Identification and sequence of the gene encoding gpIII, a major glycoprotein of varicella-zoster virus. Virology (1987) 1.66
Cell-free varicella-zoster virus in cultured human melanoma cells. J Gen Virol (1979) 1.64
Biochemical and genetic characterization of the action of triclosan on Staphylococcus aureus. J Antimicrob Chemother (2001) 1.61
Antibody response following measles-mumps-rubella vaccine under conditions of customary use. JAMA (1983) 1.60
New common nomenclature for glycoprotein genes of varicella-zoster virus and their glycosylated products. J Virol (1986) 1.59
Zoster immune globulin. A further assessment. N Engl J Med (1974) 1.57
Pathogenicity of acyclovir-resistant herpes simplex virus type 1 from an immunodeficient child. J Infect Dis (1982) 1.56
Identification and structure of the gene encoding gpII, a major glycoprotein of varicella-zoster virus. Virology (1986) 1.55
Vaccination with yeast-expressed cottontail rabbit papillomavirus (CRPV) virus-like particles protects rabbits from CRPV-induced papilloma formation. Vaccine (1995) 1.53
Amplification and rearrangement of onc genes in mammalian species. Nature (1982) 1.48
Observations on the growth of varicella-zoster virus in human diploid cells. J Gen Virol (1973) 1.48
Enzyme-linked immunosorbent assay for evaluation of immunity to measles virus. J Clin Microbiol (1984) 1.47
Blood Transfusion at the Front (Film by Dr. Frederic Duran-Jordá, Chief of the Spanish Government Blood-transfusion Service): (Section of Surgery). Proc R Soc Med (1938) 1.47
Varicella-Zoster Immunoglobulins during Varicella, Latency, and Zoster. J Infect Dis (1975) 1.47
Three major glycoprotein genes of varicella-zoster virus whose products have neutralization epitopes. J Virol (1984) 1.45
The development of multivalent bovine rotavirus (strain WC3) reassortant vaccine for infants. J Infect Dis (1996) 1.42
Recent advances in varicella-zoster virus infection. Ann Intern Med (1999) 1.41
Chickenpox--examining our options. N Engl J Med (1991) 1.41
Complement-enhanced neutralizing antibody response to varicella-zoster virus. J Infect Dis (1979) 1.40
Lack of evidence of transmission of HIV-1 to family contacts of HIV-1 infected children. Clin Pediatr (Phila) (1998) 1.40
SV40 recombinant molecules express the gene encoding p21 transforming protein of Harvey murine sarcoma virus. Nature (1981) 1.39
Trigeminal Naevus and Haemangioma of Meninges. Proc R Soc Med (1932) 1.37
Persistence of the efficacy of zoster vaccine in the shingles prevention study and the short-term persistence substudy. Clin Infect Dis (2012) 1.36
A fluorescence enhancement assay of cell fusion. J Cell Sci (1977) 1.36
Potent and selective nonpeptide inhibitors of caspases 3 and 7 inhibit apoptosis and maintain cell functionality. J Biol Chem (2000) 1.34
A fluorescence photobleaching study of vesicular stomatitis virus infected BHK cells. Modulation of G protein mobility by M protein. Biochemistry (1981) 1.34
Mouse cells contain two distinct ras gene mRNA species that can be translated into a p21 onc protein. Mol Cell Biol (1982) 1.34
Cytoplasmic 5'-nucleotidase catalyzes acyclovir phosphorylation. J Biol Chem (1985) 1.33
Unusually high-level expression of a foreign gene (hepatitis B virus core antigen) in Saccharomyces cerevisiae. Gene (1986) 1.32
Risk factors for invasive group A streptococcal infections in children with varicella: a case-control study. Pediatr Infect Dis J (1996) 1.28
Zoster, reinfection or activation of latent virus? Observations on the antibody response. Am J Med (1970) 1.28
Specific immunoglobulin M enzyme-linked immunosorbent assay for confirming the diagnosis of measles. J Clin Microbiol (1986) 1.27
Epidemic group A meningococcal disease in Haj pilgrims. Lancet (1987) 1.26
Use of a bacterial expression vector to map the varicella-zoster virus major glycoprotein gene, gC. J Virol (1985) 1.26
Genetic studies of cell fusion induced by herpes simplex virus type 1. J Virol (1980) 1.24
Cardiovascular abnormalities in Kawasaki disease. Arch Dis Child (1984) 1.24
Clinical isolate of herpes simplex virus type 2 that induces a thymidine kinase with altered substrate specificity. Antimicrob Agents Chemother (1987) 1.24
Chromosome assignments of four mouse cellular homologs of sarcoma and leukemia virus oncogenes. Proc Natl Acad Sci U S A (1984) 1.23
Tuberculosis of the central nervous system in children: a 20-year survey. J Infect (2000) 1.23
Antibody assays suitable for assessing immune responses to live varicella vaccine. Vaccine (1991) 1.22
Purification of virus-like particles of recombinant human papillomavirus type 11 major capsid protein L1 from Saccharomyces cerevisiae. Protein Expr Purif (1999) 1.21
Ichthyosis Congenita. Proc R Soc Med (1936) 1.20
Risk of herpes zoster in children with leukemia: varicella vaccine compared with history of chickenpox. Pediatrics (1986) 1.19
Protection against papillomavirus with a polynucleotide vaccine. J Infect Dis (1996) 1.19
Potent and selective nonpeptide inhibitors of caspases 3 and 7. J Med Chem (2001) 1.18
Plaque autoradiography assay for the detection and quantitation of thymidine kinase-deficient and thymidine kinase-altered mutants of herpes simplex virus in clinical isolates. Antimicrob Agents Chemother (1985) 1.17
Protein disulfide isomerase is essential for viability in Saccharomyces cerevisiae. Gene (1991) 1.16
Prevention of varicella in high risk children: a collaborative study. Pediatrics (1972) 1.16
Varicella-zoster virus as a live vector for the expression of foreign genes. Proc Natl Acad Sci U S A (1987) 1.15
Passive immunization against varicella-zoster infections and other modes of therapy. J Infect Dis (1973) 1.15
Nucleotide sequence of the two rat cellular rasH genes. Mol Cell Biol (1986) 1.15
The metabolism of carbohydrate after starvation. Biochem J (1932) 1.14
Expression of the Epstein-Barr virus gp350/220 gene in rodent and primate cells. J Virol (1987) 1.13
Effect of early immunization on antibody response to reimmunization with measles vaccine as demonstrated by enzyme-linked immunosorbent assay (ELISA). Pediatrics (1984) 1.12
Urinary screening tests to detect excessive lead absorption. Br J Ind Med (1966) 1.08
Varicella-zoster infections in pregnancy. JAMA (1967) 1.08
Identification of an Epstein-Barr virus glycoprotein which is antigenically homologous to the varicella-zoster virus glycoprotein II and the herpes simplex virus glycoprotein B. Virology (1987) 1.08
Comparison of gpELISA and neutralizing antibody responses to Oka/Merck live varicella vaccine (Varivax) in children and adults. Vaccine (1997) 1.08
Glycoprotein processing in mutants of HSV-1 that induce cell fusion. Virology (1982) 1.08
Steroid therapy and varicella. J Pediatr (1972) 1.08
The Minnesota project: a focused approach to ambulatory quality assessment. Inquiry (1990) 1.07
Osteopetrosis: (Section for the Study of Disease in Children). Proc R Soc Med (1934) 1.05
Candidate Neisseria meningitidis NspA vaccine. J Biotechnol (2000) 1.03